Kouki Miura
Department Of Head And Neck Oncology And Surgery, 1-4-3 Mita
Minato, 1088329, Japan
Minato, 1088329, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Macroscopic and multiple metastases in sentinel lymph node biopsy are respectively associated with poor prognosis in early oral cancer.
Journal: International journal of clinical oncology
Published: November 02, 2022
Preoperative S-1 Therapy for Head and Neck Carcinoma During the Waiting Period Before Surgery.
Journal: Anticancer research
Published: April 07, 2022
Postoperative Complications and Swallowing Function after Jejunal and Skin Flap Reconstruction for Hypopharyngeal Carcinoma-A Multicenter Retrospective Study.
Journal: Journal of clinical medicine
Published: January 20, 2022
Comparison of Dosage of Nivolumab in Efficacy and Safety for Recurrent Metastatic Squamous Cell Carcinoma.
Journal: Anticancer research
Published: December 27, 2021
Predictive factors for false negatives following sentinel lymph node biopsy in early oral cavity cancer.
Journal: Scientific reports
Published: November 27, 2021
Distribution pattern and pathologic analysis of metastatic sentinel and non-sentinel lymph nodes in lymphatic basin dissection for clinical T2/T3 oral cancer with clinical N0 status.
Journal: Auris, nasus, larynx
Published: October 21, 2021
Reply to P. Kaul et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 10, 2021
Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2021
Attempting to define sentinel node micrometastasis in oral squamous cell carcinoma.
Journal: Fukushima journal of medical science
Published: December 03, 2020
Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma.
Journal: Anticancer research
Published: July 11, 2020
Last Updated: 09/26/2026